(Q39910365)

English

A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancer

scientific article

Statements

A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancer (English)
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit